Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Forest Laboratories, Microbia deal

The companies will co-develop and co-market Microbia's linaclotide ( MD-1100) in

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE